Edition:
United Kingdom

Prometic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

1.56CAD
16 Feb 2018
Change (% chg)

$0.05 (+3.31%)
Prev Close
$1.51
Open
$1.55
Day's High
$1.58
Day's Low
$1.52
Volume
740,086
Avg. Vol
893,438
52-wk High
$2.64
52-wk Low
$1.12

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 17 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 6 7 6 7
(3) HOLD 4 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.08 2.09 2.08

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 10 72.98 150.36 25.60 94.61
Earnings (per share)
Year Ending Dec-18 10 -0.09 0.01 -0.16 -0.06

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 7.02 4.31 2.71 38.60
Quarter Ending Jun-17 4.84 3.62 1.22 25.21
Quarter Ending Mar-17 4.78 4.87 0.09 1.82
Quarter Ending Dec-16 5.28 4.11 1.16 22.08
Quarter Ending Sep-16 9.05 3.74 5.31 58.69
Earnings (per share)
Quarter Ending Sep-17 -0.04 -0.05 0.01 -25.00
Quarter Ending Jun-17 -0.04 -0.04 0.00 -4.08
Quarter Ending Mar-17 -0.04 -0.04 0.00 -7.62
Quarter Ending Dec-16 -0.04 -0.06 0.02 -68.07
Quarter Ending Sep-16 -0.03 -0.04 0.01 -45.45

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 72.98 72.98 69.44 67.55 94.61
Earnings (per share)
Year Ending Dec-18 -0.09 -0.09 -0.10 -0.10 -0.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 1 0
Earnings
Year Ending Dec-18 0 0 1 0